$ Value
$0
Shares
14,472
Price
$0
Filed
Jul 16
Insider
Name
Iyengar Vijay K
Title
EVP, GMAPPS
CIK
0001670000
Roles
Transaction Details
Transaction Date
2025-07-15
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
14,472
Footnotes
Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of RSUs or earned performance shares previously reported in Table I as common stock. | Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis. | Including the July 15, 2025 grant, this includes an aggregate of 37,752 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. | Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer. | The July 15, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
Filing Info
Iyengar Vijay K's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-07-16 | INCY | ▼ | $67K |
| 2025-07-15 | INCY | ▼ | $82K |
| 2025-07-15 | INCY | F | $57K |
| 2025-07-15 | INCY | A | $0 |
| 2025-07-15 | INCY | A | $0 |
| 2025-07-15 | INCY | A | $0 |
| 2025-07-14 | INCY | F | $42K |
| 2025-07-03 | INCY | ▼ | $183K |
| 2025-07-03 | INCY | ▼ | $404K |
| 2025-07-02 | INCY | F | $464K |
Other Insiders at INCY (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| HARRIGAN EDMUND | — | — | 2026-03-31 |
|
CAGNONI PABLO J
President, Global Head of R&D
|
— | $1.8M | 2026-04-17 |
| BAKER BROS. ADVISORS LP | — | — | 2026-03-31 |
| Clancy Paul J | — | — | 2026-03-31 |
|
Meury William
Chief Executive Officer
|
— | — | 2026-04-15 |
|
Stein Steven H
CMO & Head of Late-Stage Dev.
|
— | — | 2026-04-15 |
|
Trotta Matteo
EVP, GM, Dermatology US
|
— | — | 2026-03-25 |